Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Berberine (goldenseal) - Nutraceuticals World
Research

Berberine (goldenseal)

Indication: Type 2 diabetes/high cholesterol


Source: J Clin Endocrinol Metab, Apr 8, 2008 [Epub ahead of print]

Research: Researchers in China conducted a study on 116 subjects with type 2 diabetes and dyslipidemia. They were randomly assigned to receive either a placebo or berberine (1 gram daily) for a period of 3 months. Researchers were looking for changes in plasma glucose and changes in serum lipid concentrations.

Results: The results revealed that fasting blood glucose levels decreased from 7.0 to 5.6 mm/L, post load sugar levels decreased from 12.0 to 8.0 mm/L, and HbA1c (a measure of long-term diabetes control) decreased from 7.5% to 6.6% in patients receiving berberine. It was also noted that triglyceride levels decreased from 2.5 to 1.6 mm/L, total cholesterol decreased from 5.3 to 4.4 mm/L, and LDL (bad) cholesterol decreased from 3.2 to 2.6 mm/L during the course of the study in patients receiving berberine. This led the authors to conclude that berberine may be a safe and effective treatment option for type 2 diabetes and high cholesterol, although larger studies are needed to confirm these findings.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters